Caloric restriction mimetics: towards a molecular definition

Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Drug discovery 2014-10, Vol.13 (10), p.727-740
Hauptverfasser: Madeo, Frank, Pietrocola, Federico, Eisenberg, Tobias, Kroemer, Guido
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 740
container_issue 10
container_start_page 727
container_title Nature reviews. Drug discovery
container_volume 13
creator Madeo, Frank
Pietrocola, Federico
Eisenberg, Tobias
Kroemer, Guido
description Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity. Kroemer, Madeo and colleagues propose a unifying definition of caloric restriction mimetics as agents that induce autophagy by promoting protein deacetylation, which could have implications for their development as drugs. Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.
doi_str_mv 10.1038/nrd4391
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1567051439</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A385803035</galeid><sourcerecordid>A385803035</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-1790dba8506e78b027e6542f62de7d87ea7ff41393b14defe5d97e17ec20724b3</originalsourceid><addsrcrecordid>eNptkUtLAzEUhYMoVqv4D2TAhW5a885U3EjxBQU3uh4yyZ2SMjOpyQzivzfF2mqRLG5Ivns49x6EzggeE8zy6zZYziZkDx0RrviIqJzvb-5KDtBxjAuMiSSKHqIBFZRQiekRup3q2gdnsgCxS7Vzvs0a10DnTLzJOv-hg42Zzhpfg-lrHTILlWvdCjxBB5WuI5yu6xC9Pdy_Tp9Gs5fH5-ndbGQEF11yMMG21LnAElReYqpACk4rSS0omyvQqqo4YRNWEp7UQdiJAqLAUKwoL9kQXX3rLoN_75PRonHRQF3rFnwfCyKkwoKkDST0Ygdd-D60yd2KkpJRRfGWmusaCtdWvgvarESLO5aLHDPMRKLG_1DpWGic8W3aQ3r_03D53WCCjzFAVSyDa3T4LAguVjkV65wSeb622ZcN2A33E8x25Ji-2jmEX3PsaH0BhaKYDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566632720</pqid></control><display><type>article</type><title>Caloric restriction mimetics: towards a molecular definition</title><source>MEDLINE</source><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Madeo, Frank ; Pietrocola, Federico ; Eisenberg, Tobias ; Kroemer, Guido</creator><creatorcontrib>Madeo, Frank ; Pietrocola, Federico ; Eisenberg, Tobias ; Kroemer, Guido</creatorcontrib><description>Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity. Kroemer, Madeo and colleagues propose a unifying definition of caloric restriction mimetics as agents that induce autophagy by promoting protein deacetylation, which could have implications for their development as drugs. Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.</description><identifier>ISSN: 1474-1776</identifier><identifier>EISSN: 1474-1784</identifier><identifier>DOI: 10.1038/nrd4391</identifier><identifier>PMID: 25212602</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/154/555 ; 631/337/458/1275 ; 631/80/39 ; 692/699/2743/2037 ; Acetyl Coenzyme A - metabolism ; Acetylation - drug effects ; Acetyltransferases - antagonists &amp; inhibitors ; Animals ; Autophagy - drug effects ; Biomedicine ; Biotechnology ; Caloric Restriction - methods ; Cancer Research ; Drug Design ; Drug therapy ; Humans ; Innovations ; Medicinal Chemistry ; Metabolic diseases ; Molecular Medicine ; Molecular targeted therapy ; opinion-2 ; Pharmacology, Experimental ; Pharmacology/Toxicology ; Weight reducing preparations</subject><ispartof>Nature reviews. Drug discovery, 2014-10, Vol.13 (10), p.727-740</ispartof><rights>Springer Nature Limited 2014</rights><rights>COPYRIGHT 2014 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Oct 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-1790dba8506e78b027e6542f62de7d87ea7ff41393b14defe5d97e17ec20724b3</citedby><cites>FETCH-LOGICAL-c545t-1790dba8506e78b027e6542f62de7d87ea7ff41393b14defe5d97e17ec20724b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25212602$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Madeo, Frank</creatorcontrib><creatorcontrib>Pietrocola, Federico</creatorcontrib><creatorcontrib>Eisenberg, Tobias</creatorcontrib><creatorcontrib>Kroemer, Guido</creatorcontrib><title>Caloric restriction mimetics: towards a molecular definition</title><title>Nature reviews. Drug discovery</title><addtitle>Nat Rev Drug Discov</addtitle><addtitle>Nat Rev Drug Discov</addtitle><description>Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity. Kroemer, Madeo and colleagues propose a unifying definition of caloric restriction mimetics as agents that induce autophagy by promoting protein deacetylation, which could have implications for their development as drugs. Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.</description><subject>631/154/555</subject><subject>631/337/458/1275</subject><subject>631/80/39</subject><subject>692/699/2743/2037</subject><subject>Acetyl Coenzyme A - metabolism</subject><subject>Acetylation - drug effects</subject><subject>Acetyltransferases - antagonists &amp; inhibitors</subject><subject>Animals</subject><subject>Autophagy - drug effects</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Caloric Restriction - methods</subject><subject>Cancer Research</subject><subject>Drug Design</subject><subject>Drug therapy</subject><subject>Humans</subject><subject>Innovations</subject><subject>Medicinal Chemistry</subject><subject>Metabolic diseases</subject><subject>Molecular Medicine</subject><subject>Molecular targeted therapy</subject><subject>opinion-2</subject><subject>Pharmacology, Experimental</subject><subject>Pharmacology/Toxicology</subject><subject>Weight reducing preparations</subject><issn>1474-1776</issn><issn>1474-1784</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkUtLAzEUhYMoVqv4D2TAhW5a885U3EjxBQU3uh4yyZ2SMjOpyQzivzfF2mqRLG5Ivns49x6EzggeE8zy6zZYziZkDx0RrviIqJzvb-5KDtBxjAuMiSSKHqIBFZRQiekRup3q2gdnsgCxS7Vzvs0a10DnTLzJOv-hg42Zzhpfg-lrHTILlWvdCjxBB5WuI5yu6xC9Pdy_Tp9Gs5fH5-ndbGQEF11yMMG21LnAElReYqpACk4rSS0omyvQqqo4YRNWEp7UQdiJAqLAUKwoL9kQXX3rLoN_75PRonHRQF3rFnwfCyKkwoKkDST0Ygdd-D60yd2KkpJRRfGWmusaCtdWvgvarESLO5aLHDPMRKLG_1DpWGic8W3aQ3r_03D53WCCjzFAVSyDa3T4LAguVjkV65wSeb622ZcN2A33E8x25Ji-2jmEX3PsaH0BhaKYDA</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Madeo, Frank</creator><creator>Pietrocola, Federico</creator><creator>Eisenberg, Tobias</creator><creator>Kroemer, Guido</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20141001</creationdate><title>Caloric restriction mimetics: towards a molecular definition</title><author>Madeo, Frank ; Pietrocola, Federico ; Eisenberg, Tobias ; Kroemer, Guido</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-1790dba8506e78b027e6542f62de7d87ea7ff41393b14defe5d97e17ec20724b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>631/154/555</topic><topic>631/337/458/1275</topic><topic>631/80/39</topic><topic>692/699/2743/2037</topic><topic>Acetyl Coenzyme A - metabolism</topic><topic>Acetylation - drug effects</topic><topic>Acetyltransferases - antagonists &amp; inhibitors</topic><topic>Animals</topic><topic>Autophagy - drug effects</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Caloric Restriction - methods</topic><topic>Cancer Research</topic><topic>Drug Design</topic><topic>Drug therapy</topic><topic>Humans</topic><topic>Innovations</topic><topic>Medicinal Chemistry</topic><topic>Metabolic diseases</topic><topic>Molecular Medicine</topic><topic>Molecular targeted therapy</topic><topic>opinion-2</topic><topic>Pharmacology, Experimental</topic><topic>Pharmacology/Toxicology</topic><topic>Weight reducing preparations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madeo, Frank</creatorcontrib><creatorcontrib>Pietrocola, Federico</creatorcontrib><creatorcontrib>Eisenberg, Tobias</creatorcontrib><creatorcontrib>Kroemer, Guido</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madeo, Frank</au><au>Pietrocola, Federico</au><au>Eisenberg, Tobias</au><au>Kroemer, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caloric restriction mimetics: towards a molecular definition</atitle><jtitle>Nature reviews. Drug discovery</jtitle><stitle>Nat Rev Drug Discov</stitle><addtitle>Nat Rev Drug Discov</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>13</volume><issue>10</issue><spage>727</spage><epage>740</epage><pages>727-740</pages><issn>1474-1776</issn><eissn>1474-1784</eissn><abstract>Caloric restriction can promote health and extend the lifespan of model organisms, and diverse classes of compounds that mimic the biochemical and functional effects of caloric restriction have attracted considerable interest as potential pharmacotherapies for diseases such as diabetes and obesity. Kroemer, Madeo and colleagues propose a unifying definition of caloric restriction mimetics as agents that induce autophagy by promoting protein deacetylation, which could have implications for their development as drugs. Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>25212602</pmid><doi>10.1038/nrd4391</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1474-1776
ispartof Nature reviews. Drug discovery, 2014-10, Vol.13 (10), p.727-740
issn 1474-1776
1474-1784
language eng
recordid cdi_proquest_miscellaneous_1567051439
source MEDLINE; Nature; Alma/SFX Local Collection
subjects 631/154/555
631/337/458/1275
631/80/39
692/699/2743/2037
Acetyl Coenzyme A - metabolism
Acetylation - drug effects
Acetyltransferases - antagonists & inhibitors
Animals
Autophagy - drug effects
Biomedicine
Biotechnology
Caloric Restriction - methods
Cancer Research
Drug Design
Drug therapy
Humans
Innovations
Medicinal Chemistry
Metabolic diseases
Molecular Medicine
Molecular targeted therapy
opinion-2
Pharmacology, Experimental
Pharmacology/Toxicology
Weight reducing preparations
title Caloric restriction mimetics: towards a molecular definition
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A24%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caloric%20restriction%20mimetics:%20towards%20a%20molecular%20definition&rft.jtitle=Nature%20reviews.%20Drug%20discovery&rft.au=Madeo,%20Frank&rft.date=2014-10-01&rft.volume=13&rft.issue=10&rft.spage=727&rft.epage=740&rft.pages=727-740&rft.issn=1474-1776&rft.eissn=1474-1784&rft_id=info:doi/10.1038/nrd4391&rft_dat=%3Cgale_proqu%3EA385803035%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1566632720&rft_id=info:pmid/25212602&rft_galeid=A385803035&rfr_iscdi=true